These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a se...t of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the national health sector response to HIV.
more
Bulletin of the World Health Organization, 2000, 78 (6)
This guidance aims to support national clusters to implement their commitments on AAP and core people-related issues both before the beginning of a response (preparedness) and thereafter, throughout the...pan> Humanitarian Programme Cycle (HPC)
more
Updated 22 august 2016. This document aims to provide interim guidance on the case definition of GBS and strategies to manage the syndrome, in the ...context of Zika virus and its potential association with GBS. This document is intended to inform the development of local clinical protocols and health policies related to the care of patients with GBS
more
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past dec...ade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and health systems response that will allow NCDs and their contributing risk factors to be successfully contained and reversed.
more
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, ...e-to-highlight medbox">the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the revision of the recommendation regarding the use of 80% fraction of inspired oxygen (high FiO2) in surgical patients under general anaesthesia with tracheal intubation and the update of the section on implementation. Between 2017 and 2018, WHO re-assessed the evidence on the use of high FiO2 by updating the systematic review related to the effectiveness of this intervention to reduce SSI and commissioning an independent systematic review on adverse events potentially associated with it. Based on the updated evidence, the GDG decided to revise the strength of the recommendation from strong to conditional.
more
Guidelines
HIV drug resistance
July 2017
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013